If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Sanlam LA6S Apr 25, 2025 7.40 +0.68   
 Sanlorenzo S.p.a. 6SZA Apr 25, 2025 27.75 +4.13   
 Sanmina Corporation SAYN Apr 25, 2025 71.76 +9.39   
 Sanofi SNW Apr 25, 2025 92.72 +1.86   
 Sanofi - American Depositary Shares SNW2 Apr 25, 2025 45.80 +1.78   
 Sanok Rubber Company SA 1NX Apr 25, 2025 4.44 +0.91   
 Sanoma SNQB Apr 25, 2025 9.45 -1.36   
 Sanrio Company Ltd. SJ8 Apr 25, 2025 35.60 0.00   
 Santacruz Silver Mining Ltd 1SZ Apr 25, 2025 0.32 -2.70   
 Santander Bank Polska S. A. BZI Apr 25, 2025 144.25 +11.13   
 Santen Pharmaceutical Co. Ltd. SZD Apr 25, 2025 8.45 +1.20   
 Santorius AG Unsponsored ADR (Germany) SRT4 Apr 25, 2025 37.20 +8.77   
 Santos Ltd STS1 Apr 25, 2025 3.30 +5.13   
 Sanu Gold Corp L73 Apr 25, 2025 0.21 -16.41   
 Sanwa Holdings Corp. XST Apr 25, 2025 27.60 0.00   
 SANY INTL YXS Apr 25, 2025 0.64 +9.78   
 Sanyo Chemical Industries Ltd. XSI Apr 25, 2025 21.80 +1.87   
 SAP SE ADS SAPA Apr 25, 2025 240.00 +6.19   
 Sap SE SAP Apr 25, 2025 244.50 +8.23   
 SAP SE CDR O.N. SAP0 Apr 25, 2025 14.30 0.00   
 Sapiens International Corporation N.V. - S3P Apr 25, 2025 24.00 +5.26   
 Sappi Ltd SPIA Apr 25, 2025 1.52 -3.18   
 Sappi Ltd SPI Apr 25, 2025 1.62 -2.99   
 Sapporo Holdings Ltd. SBW Apr 25, 2025 47.80 -4.40   
 Saputo Inc SB7 Apr 25, 2025 16.78 +3.10   
 Sarama Resources Ltd 48S1 Apr 25, 2025 0.00 -59.09   
 SARATOGA INVES.SED.RP 100 ZY8 Apr 25, 2025 0.04 -2.35   
 Saratoga Investment New QJ8 0.00 0.00   
 Sarepta Therapeutics, Inc. AB3A Apr 25, 2025 54.40 +14.91   
 Sareum Holdings Plc RYH0 Apr 25, 2025 0.16 -11.17   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.